
Press Release|Articles|March 8, 2024
Camber Pharmaceuticals Launches Generic Vascepa®
Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.
Advertisement
Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.
Icosapent Ethyl Capsules are an ethyl ester of eicosapentaenoic acid (EPA) indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.
Icosapent Ethyl Capsules are available in:
- 0.5 gram - 240 count bottles
- 1 gram - 120 count bottles
To find out more about Icosapent Ethyl Capsule, please visit
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Advanced Technology Is Reshaping Medication Safety and Pharmacy Practice
2
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
3
Single Dose of Psilocybin Demonstrates Rapid Relief of Depression Symptoms in Phase 2 Trial
4
How Clinical Pharmacists Optimize Obstructive Hypertrophic Cardiomyopathy Care
5
































































































































